David D. Arrington, Ph.D. - Publications

Medical University of South Carolina, Charleston, SC, United States 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Covington MD, Arrington DD, Schnellmann RG. Calpain 10 is required for cell viability and is decreased in the aging kidney. American Journal of Physiology. Renal Physiology. 296: F478-86. PMID 19144693 DOI: 10.1152/ajprenal.90477.2008  1
2009 Rasbach KA, Arrington DD, Odejinmi S, Giguere C, Beeson CC, Schnellmann RG. Identification and optimization of a novel inhibitor of mitochondrial calpain 10. Journal of Medicinal Chemistry. 52: 181-8. PMID 19072163 DOI: 10.1021/jm800735d  1
2008 Arrington DD, Schnellmann RG. Targeting of the molecular chaperone oxygen-regulated protein 150 (ORP150) to mitochondria and its induction by cellular stress. American Journal of Physiology. Cell Physiology. 294: C641-50. PMID 18094145 DOI: 10.1152/ajpcell.00400.2007  1
2006 Arrington DD, Van Vleet TR, Schnellmann RG. Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction. American Journal of Physiology. Cell Physiology. 291: C1159-71. PMID 16790502 DOI: 10.1152/ajpcell.00207.2006  1
2002 Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney International. 61: 939-50. PMID 11849448 DOI: 10.1046/j.1523-1755.2002.00207.x  1
Show low-probability matches.